Jia Lu Selected Research

preprotachykinin

11/2010	Substance P upregulates cyclooxygenase-2 and prostaglandin E metabolite by activating ERK1/2 and NF-kappaB in a mouse model of burn-induced remote acute lung injury.
1/2010	Early protection from burn-induced acute lung injury by deletion of preprotachykinin-A gene.
6/2008	The neuropeptide substance P is a critical mediator of burn-induced acute lung injury.
3/2006	Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia Lu Research Topics

Disease

32	Neoplasms (Cancer) 02/2022 - 04/2007
12	Infections 04/2022 - 01/2008
11	COVID-19 04/2022 - 01/2020
11	Hypoxia (Hypoxemia) 02/2013 - 01/2007
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 03/2003
7	Inflammation (Inflammations) 01/2019 - 06/2008
7	Colorectal Neoplasms (Colorectal Cancer) 08/2018 - 05/2008
6	Myocardial Infarction 01/2022 - 01/2007
5	Caliciviridae Infections 01/2022 - 01/2017
5	Rupture 01/2022 - 01/2016
5	Hemorrhagic Shock 09/2020 - 02/2003
5	Infarction (Infarctions) 01/2016 - 12/2004
5	Brain Injuries (Brain Injury) 02/2015 - 02/2003
5	Wounds and Injuries (Trauma) 02/2015 - 11/2008
5	Acute Lung Injury 01/2014 - 06/2008
5	Burns 01/2014 - 06/2008
4	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2014
4	Tuberculosis (Tuberculoses) 01/2021 - 07/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 10/2006
3	Thoracic Aortic Aneurysm 04/2021 - 10/2015
3	Neuroinflammatory Diseases 01/2021 - 01/2011
3	Sepsis (Septicemia) 01/2021 - 03/2006
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 08/2014
3	Cardiac Arrhythmias (Arrythmia) 04/2015 - 01/2009
2	Parkinson Disease (Parkinson's Disease) 05/2022 - 12/2019
2	Body Weight (Weight, Body) 04/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 12/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2021
2	Chickenpox 12/2021 - 12/2014
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2019
2	Adenocarcinoma 01/2021 - 05/2008
2	Memory Disorders (Memory Loss) 01/2021 - 01/2021
2	Retinoblastoma (Glioblastoma, Retinal) 01/2020 - 05/2019
2	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2018
2	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2020 - 01/2019
2	Glioma (Gliomas) 01/2020 - 06/2017
2	Stroke (Strokes) 01/2019 - 04/2009
2	Gastroenteritis 01/2018 - 11/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 10/2016
2	Gliosis 01/2016 - 11/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2016 - 11/2015
2	Edema (Dropsy) 10/2014 - 07/2013

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2006
12	CytokinesIBA 01/2021 - 07/2007
12	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2011 - 02/2003
10	VaccinesIBA 04/2022 - 01/2011
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2007
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 05/2008
8	Messenger RNA (mRNA)IBA 05/2018 - 04/2007
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011 - 02/2003
6	N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA 01/2022 - 10/2015
6	Small Interfering RNA (siRNA)IBA 11/2021 - 04/2007
6	pimagedine (aminoguanidine)IBA 02/2005 - 02/2003
5	Pharmaceutical PreparationsIBA 02/2022 - 01/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2007
5	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021 - 07/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 01/2008
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
4	CollagenIBA 01/2022 - 01/2011
4	Biological ProductsIBA 01/2019 - 01/2007
4	salicylhydroxamic acid (SHAM)IBA 02/2015 - 01/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 01/2008
4	preprotachykininIBA 11/2010 - 03/2006
4	Substance PIBA 11/2010 - 03/2006
4	Nitric Oxide Synthase (NO Synthase)IBA 08/2005 - 02/2003
3	Inactivated VaccinesIBA 10/2021 - 12/2020
3	Immunoglobulin G (IgG)IBA 08/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2014
3	C-Reactive ProteinIBA 01/2021 - 02/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2012
3	polycaprolactoneIBA 02/2015 - 01/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 08/2005
3	ChemokinesIBA 11/2010 - 03/2006
3	NeuropeptidesIBA 11/2010 - 06/2008
2	AntibodiesIBA 04/2022 - 01/2017
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 07/2008
2	Therapeutic UsesIBA 10/2021 - 07/2021
2	LipidsIBA 02/2021 - 01/2021
2	Amino Acids FDA Link 01/2021 - 12/2012
2	Retinaldehyde (Retinal)IBA 01/2021 - 07/2018
2	InterferonsIBA 01/2021 - 09/2013
2	ras ProteinsIBA 01/2020 - 01/2017
2	NucleotidesIBA 12/2019 - 07/2011
2	Protein Kinases (Protein Kinase)IBA 12/2019 - 06/2012
2	LipopolysaccharidesIBA 01/2019 - 02/2011
2	Alkaline PhosphataseIBA 01/2019 - 01/2017
2	Gemcitabine FDA Link 05/2018 - 01/2016
2	EnzymesIBA 01/2017 - 12/2013
2	Interleukin-2 (IL2)IBA 01/2017 - 10/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 09/2013
2	scutellarinIBA 01/2016 - 11/2015
2	CreatinineIBA 02/2015 - 01/2014
2	SmokeIBA 10/2014 - 01/2009

Therapy/Procedure

12	Therapeutics 02/2022 - 04/2007
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 10/2020
3	Immunotherapy 01/2022 - 10/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 11/2011
3	Resuscitation 01/2014 - 02/2003